Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03692429
Brief Title: alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells (alloSHRINK)

First Submitted : August 31, 2018
First Submitted that Met QC Criteria : October 1, 2018
First Posted : October 2, 2018

Last Update Submitted that Met QC Criteria : November 30, 2018
Last Update Posted : December 3, 2018